McKesson Co. (MCK) Receives $136.99 Average Price Target from Brokerages
Shares of McKesson Co. (NYSE:MCK) have earned an average rating of “Hold” from the fifteen research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $136.99.
MCK has been the subject of a number of research reports. Royal Bank of Canada set a $155.00 price target on shares of McKesson and gave the stock a “hold” rating in a report on Friday, October 26th. Barclays reduced their price target on shares of McKesson from $150.00 to $136.00 and set an “equal weight” rating for the company in a report on Friday, October 26th. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a report on Monday, October 29th. Morgan Stanley reduced their price target on shares of McKesson from $142.00 to $130.00 and set an “equal weight” rating for the company in a report on Monday, December 3rd. Finally, Zacks Investment Research cut shares of McKesson from a “hold” rating to a “sell” rating in a report on Thursday, January 3rd.
Shares of MCK traded down $0.42 during trading hours on Friday, hitting $121.62. 90,938 shares of the stock were exchanged, compared to its average volume of 1,839,348. McKesson has a fifty-two week low of $106.11 and a fifty-two week high of $178.86. The company has a quick ratio of 0.56, a current ratio of 0.99 and a debt-to-equity ratio of 0.69. The stock has a market cap of $23.11 billion, a PE ratio of 9.66, a price-to-earnings-growth ratio of 1.35 and a beta of 1.06.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 2nd. Stockholders of record on Monday, December 3rd were issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Friday, November 30th. McKesson’s dividend payout ratio is currently 12.36%.
Several hedge funds and other institutional investors have recently modified their holdings of MCK. IMS Capital Management acquired a new position in shares of McKesson during the third quarter valued at about $57,000. Fort L.P. acquired a new position in shares of McKesson during the second quarter valued at about $110,000. Flagship Harbor Advisors LLC acquired a new position in shares of McKesson during the second quarter valued at about $118,000. Reilly Financial Advisors LLC grew its holdings in shares of McKesson by 506.8% during the third quarter. Reilly Financial Advisors LLC now owns 898 shares of the company’s stock valued at $119,000 after buying an additional 750 shares during the last quarter. Finally, Bray Capital Advisors acquired a new position in shares of McKesson during the third quarter valued at about $123,000. Hedge funds and other institutional investors own 85.31% of the company’s stock.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Further Reading: What is net income?
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.